|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |
Abstract |
|---|
|
|
|---|
Surfactant protein D (SP-D), which has structural homology to C-type lectin binding regions, may play a role in host defense and has no known surfactant function. Because other surfactant proteins have been shown to be increased after prolonged periods of hyperoxia, we sought to evaluate the early effects of hyperoxia (95% O2) on expression of SP-D in the adult male rat lung. Animals were exposed to air or to 12, 36, or 60 h of 95% O2. Northern blot analysis of total lung RNA revealed marked SP-D mRNA increases at 12 h 95% O2 compared with air-exposed controls, with decreasing expression to near that of air-exposed animals by 60 h. Semiquantitative in situ RNA hybridization demonstrated parallel results, with increased numbers of labeled alveolar epithelial (AE) and bronchiolar epithelial (BE) cells at 12 h and increased intensity of labeled alveolar cells, compared with air-exposed controls. After 60 h of exposure to 95% O2, mRNA label intensity in AE and BE was decreased to levels near those seen in air-exposed animals. In contrast, Western blotting showed a decline in total lung SP-D with 95% O2 exposure, beginning at 12 h and continuing at 36 and 60 h, respectively. Semiquantitative immunohistochemistry demonstrated a decline in AE labeling parallel to the total lung Western blot results, but labeled total BE cell numbers increased (P = 0.10). Hyperoxia had differential effects on SP-D abundance in AE and BE cells, and therefore may influence the availability of SP-D to bind microbial pathogens in the airways depending on cell type and location.
| |
Introduction |
|---|
|
|
|---|
Surfactant protein D (SP-D) has been isolated with lavaged lung surfactant but has no known role in reducing surface tension in the lung. Its molecular structure and cDNA sequence are highly homologous to SP-A, particularly in the carbohydrate recognition domain common to all C-type lectins (1). Evidence for a role for SP-D in lung host defense includes its enhancement of oxygen radical-mediated killing in rat alveolar macrophages (2, 3), significant binding to Escherichia coli and other gram-negative bacteria in isolated bronchoalveolar lavage (4), and significant calcium-dependent binding of the carbohydrate domains of Pneumocystis carinii (7). SP-D may provide protection against pulmonary influenza A infection (8- 12), although it does not appear to opsonize influenza A for alveolar macrophages in the rat (13).
Hyperoxia has been used as a model of acute and chronic lung injury. Data on effects on gene expression following relatively brief oxygen exposures are limited. The earliest events in oxygen-mediated toxicity are as yet unknown, and may include alterations in host defense, as has been shown with more prolonged oxygen exposure (14). Responses to prolonged acute hyperoxia appear to be differentially regulated among the surfactant proteins (15). Previous studies have, in general, examined the effects of exposures > 24 h, and FIO2, > 80%.
Because of the potentially important role of SP-D in lung defense, we postulated that lung injury might alter the abundance of SP-D, thereby potentially increasing pulmonary susceptibility to pathogens. Our experiments were designed to test the hypothesis that 95% O2 exposure- mediated lung injury would reduce SP-D abundance.
| |
Materials and Methods |
|---|
|
|
|---|
Reagents were obtained from Sigma Chemical Co. (St. Louis, MO) unless otherwise specified. Adult male Sprague-Dawley rats (Charles River Laboratories, Wilmington, MA) were exposed to 95% O2 and 5% air or to air alone in sealed Plexiglas cages 60 × 45 × 25 cm. CO2 was removed with a soda lime trap, and oxygen concentrations in the chambers were monitored with a continuous oxygen sensor (Servomex 572, Norwood, MA). Exposures were interrupted at 12 h intervals for < 10 min to clean cages and replenish food and water supplied ad libitum. Six animals were exposed to each condition: air or 95% O2 for 12, 36, and 60 h. Animals were killed after exposure with sodium pentobarbital 160 mg/kg intraperitoneally. For RNA and protein isolation lungs from six animals per treatment condition, for a total of 24, were excised and flash-frozen in liquid nitrogen. For immunohistochemistry and in situ RNA hybridization, an additional six animals per treatment condition, for a total of 24, were used. Lungs were inflated and fixed in situ with 10% phosphate-buffered formalin at 20 cm H2O inflation pressure. Tracheae were ligated and lungs and trachea were removed en bloc, fixed overnight, paraffin embedded, and sectioned at 4 to 6 µm.
Northern Blots
Frozen lungs were weighed, pulverized under liquid nitrogen, and thoroughly mixed. Total RNA was isolated by
homogenizing 1 g (approximately 10% of the entire lung)
of tissue per animal, with a Tissue Mizer (Tekmar, Cincinnati, OH) homogenizer in guanidinium isothiocyanate 1 M
buffer as previously described (18). Total RNA was extracted in acid-equilibrated phenol and phenol:chloroform and precipitated with ethanol and sodium acetate. Yields
and purity were determined by ultraviolet (UV) spectrophotometry at 260 and 280 nm, and yields per lung were
calculated using the weights of the excised frozen lung for
each animal. Ten-microgram samples of total lung RNA
from air- and hyperoxia-exposed animals were denatured
in formaldehyde and formamide and electrophoresed in formaldehyde-agarose 1.2% in 1× 3-(N-Morpholino)propanesulfonic acid buffer for 2 to 3 h (19). Equal loading
was verified by staining with ethidium bromide 0.5 µg/ml
in ammonium acetate 0.3 M for 20 min, followed by long-wave UV transillumination. Gels were rinsed in diethylpyrocarbonate-treated water, and RNA was capillary blotted
onto charged Nylon membranes (Magna, Westboro, MA)
overnight, which were then UV crosslinked with 150 mJ.
Hybridization conditions were as follows: 5× saline sodium citrate (SSC); 1× Denhardt's solution; 10% dextran;
0.5 mg/ml salmon sperm DNA; 10 mM Tris-HCl, pH 7.5;
1 mM ethylenediamine tetraacetic acid (EDTA), pH 7.5;
and SP-D cDNA probe (gift of James Fisher [20]), labeled
by nick translation according the manufacturer's instructions (BRL, Gaithersburg, MD) to an activity of 106 precipitable cpm/ml of 32P
deoxyadenosine triphosphate. Membranes were hybridized overnight at 45°C, and washed in
2× SSC 0.5% sodium dodecyl sulfate (SDS) twice at room
temperature followed by a wash in 0.1× SSC, 0.5% SDS at
62°C. Autoradiography was performed with Kodak XAR
5 film (Kodak, Rochester, NY) for 1 to 3 d at
70°C with
an intensifying screen (Cronex; DuPont, Wilmington, DE).
Membranes were reprobed with an 18S RNA cDNA probe,
nucleotides 890 to 1108 (21), labeled as above, using the
same hybridization conditions, to control for symmetry of
RNA sample loading and transfer.
Western Blotting
Rabbit antirat SP-D (gift of Jo Rae Wright and Samuel
Hawgood) was used for the immunoblots and immunohistochemistry and has previously been characterized (22,
23). Pulverized frozen rat lung was sonicated and briefly
homogenized on ice using a microhomogenizer (KONTES, Vineland, NJ) in sample buffer, final concentration
1% SDS, 20% glycerol, 2%
-mercaptoethanol, 10 mM Tris-HCl, pH 6.8. Protein concentrations were determined
in triplicate using the Bio-Rad protein assay (Bio-Rad,
Hercules, CA). Fifty microgram samples from six animals
at each exposure condition were analyzed using 10% SDS-
polyacrylamide gel electrophoresis gels, with visible (Novex,
San Diego, CA) and biotinylated (MW Protein Standards,
Broad Range; Bio-Rad) protein size standards. Gels were
blotted onto nitrocellulose (ECL; Amersham, Arlington Heights, IL) between two sheets of 3 MM filter paper
(Whatman, Clifton, NJ) in a transfer tank using 192 mM
glycine, 20% methanol, 25 mM Tris-HCl, pH 8.0, under
constant 300 mA current, with stirring at 4°C for 3 h. Transfer was verified by staining the gel and the nitrocellulose
(after detection) with Coomassie blue (24), as well as an
additional nitrocellulose membrane between the transfer membrane and the filter paper on the anode side. Membranes were blocked for 2 h in 5% low-fat milk in phosphate-buffered saline-0.1% Tween-20 (PBS-T), then washed
three times for 10 min in PBS-T. Membranes were incubated
in rabbit antirat SP-D 1:1,000 in PBS-T for 1 h, washed three
times for 10 min each in PBS-T, then detected with biotinylated goat-antirabbit serum 1:1,000 in PBS-T for 1 h
(Vector, Burlingame, CA). Membranes were again washed
three times in PBS-T and then incubated for 45 min in avidin-horseradish peroxidase conjugate 1:1,000 in PBS-T (Bio-Rad). These were detected using the ECL system according
to the manufacturer's instructions (Amersham). Autofluorograms were exposed for 0.5 to 1.5 min using BioMax film (Kodak).
In Situ Hybridizations
These were performed as previously described with the following modifications (25). Paraffin-embedded 4-µm sections were deparaffinized in xylene, rehydrated, and treated with Proteinase K 1 µg/ml for 0.5 h at 37°C. Sections were hybridized with antisense 11-digoxigenin uridine triphosphate-labeled cRNA riboprobes transcribed from the SP-D cDNA according to the manufacturer's directions (Boehringer Mannheim, Indianapolis, IN) (26). The SP-D cRNA transcript was subjected to alkaline hydrolysis to reduce the transcript length to an average of 0.15 kb as determined by agarose gel electrophoresis. Probe and carbonate buffer were added to achieve a final concentration of 0.1 M carbonate buffer, pH 10.2 (40 mM NaHCO3, 180 mM Na2CO3), and incubated at 60°C for 20 to 25 min according the method of Cox and colleagues (27). Hybridization and detection employed 0.15 M NaCl; 0.1 M Tris-HCl, pH 7.5 (buffer 1); 2% blocking reagent in buffer 1 (buffer 2); 0.1 M NaCl; 0.1 M Tris-HCl; and 0.05 M MgCl2, pH 9.5 (buffer 3) (Boehringer Mannheim). Hybridization conditions were as follows: 5× SSC, 1× Denhardt's solution; 50% formamide; 10% dextran sulfate; 10 mM Tris-HCl, pH 7.5; 1 mM EDTA, pH 7.5; 1% blocking reagent; 0.5 µg/ml cRNA probe, 100 µl/section encircled by a hydrophobic film (PAP pen; Research Products International, Mount Prospect, IL). After overnight hybridization in moist chambers containing 5× SSC/50% formamide at 45°C, sections were washed in 2× SSC for 10 min followed by RNase A 10 µg/ ml, RNase T1 0.01 U/ml in 0.5 M NaCl; 10 mM Tris-HCl, pH 7.5; and 1 mM EDTA, pH 7.5 for 30 min at 37°C (Boehringer Mannheim). Sections were washed in RNase buffer an additional 30 min at 37°C. A high-stringency wash was performed in 400 ml 0.1× SSC at 60°C for 15 min. Detection was performed by blocking the sections with buffer 2 for 1 h, adsorbing away the buffer from the edge of the section, then incubating sections with antidigoxigenin antibody-alkaline phosphatase conjugate 1:500 in buffer 2, 100 µl/section overnight at 4°C. The antibody was washed off in two 10-min washes in buffer 1, followed by a 2-min incubation in buffer 3. Excess buffer was adsorbed from near the edge of the section, which was then covered with 200 µl of substrate (nitroblue tetrazolium 337.5 µg/ml, 5-bromo-4-chloro-3-indolyl phosphate toluidinium 175 µg/ml in buffer 3) and incubated at room temperature in the dark for 2 h. Controls included sections hybridized with sense 11-digoxigenin-labeled RNA probes and sections that were treated with RNase A as above before hybridization. Color development was stopped in Tris-HCl 10 mM, pH 7.5, EDTA 5 mM, pH 7.5, and mounted in Gelvatol prior to photomicroscopy. Experiments were performed on multiple lung sections of six different animals for each exposure condition. Photomicrographs were done with an Olympus Vanox-S AH-2 microscope (Olympus America, Melville, NY).
Immunohistochemistry
Immunohistochemistry was performed as previously described (17). Sections from air- and hyperoxia-exposed animals were dewaxed in xylene for 10 min twice, then rehydrated through graded ethanols and equilibrated in Tris-buffered saline (TBS). The sections were treated with 0.1% trypsin; 0.1% CaCl2; 20 mM Tris-HCl, pH 7.5, for 5 min at room temperature, then washed in TBS for 5 min. The sections were treated with 0.3% hydrogen peroxide in methanol for 30 min, followed by 10-min washes in TBS and 0.05% Triton X-100 in TBS, followed by 20 min in 3% bovine serum albumin (Boehringer Mannheim) in TBS at room temperature. Excess buffer was adsorbed from near the section edge, and sections were encircled with a hydrophobic film (PAP Pen; Research Products International) before overlaying with 100 µl of rabbit antirat SP-D 1:1,000 in TBS. Antibody had been preadsorbed with an equal volume of rat serum overnight at 4°C before centrifugation at 14,000 × g for 10 min. Control slides were similarly treated throughout, omitting the primary antibody. Sections were then detected using the Vectastain ABC Elite kit (Vector Labs, Burlingame, CA), rinsed in TBS, and incubated with biotinylated goat antirabbit IgG, according to the manufacturer's instructions. Sections were rinsed in TBS, incubated for 1 h in Vectastain ABC reagent, rinsed in TBS, and incubated at room temperature for 2 to 10 min in 0.05% diaminobenzidine tetrahydrochloride; 0.01% hydrogen peroxide; 0.05 M Tris-HCl, pH 7.2. After color development, sections were rinsed in distilled water, dehydrated through graded ethanol, and mounted with Permount (Fisher, Pittsburgh, PA) before photomicroscopy.
Cell Counting
The number of alveolar epithelial type II and nonciliated bronchiolar epithelial Clara cells as well as the distribution of labeled mRNA for SP-D and the immunohistochemical labeling for SP-D was determined by standard morphometric methods that have been described in detail previously (28, 29). Labeled cells were counted using an eyepiece-counting graticule in 50 randomly selected high-power fields (magnification: ×400). The section area counted per high-power field was 0.025 mm2. Gunderson's unbiased counting rules were used to eliminate size-dependent edge effects in counting cells that crossed the boundaries of the counting field (32). Calculations of the total cell numbers per lung were based on these determinations of cell number per field, a section thickness of 4 µm, and the average or mean caliper diameter of 9.6 µm for Clara cells and 9.4 µm for type II cells as previously described (29). In both immunohistochemistry and in situ RNA hybridization experiments, labeled cells were classified according to intensity. Low-intensity cells demonstrated a signal just discernible above background, medium-intensity cells demonstrated homogeneous staining across the entire diameter of the cell but with preservation of visible intracellular detail, and high-intensity cells were homogeneously labeled at sufficient intensity to obliterate intracellular detail, as demonstrated in Figure 3. Unlabeled type II cells and Clara cells were also counted. The total number of cells and the number of type II and Clara cells in each condition were determined by counting unlabeled cells on a similar number of hematoxylin- and eosin-stained sections.
|
Statistical comparisons were made using analysis of variance, with significance determined to be P < 0.05. Calculations were done on a Macintosh computer (Apple Computer, Cupertino, CA) using Excel (Microsoft, Seattle, WA).
| |
Results |
|---|
|
|
|---|
Northern and Western blotting. SP-D mRNA in whole lung was increased at 12 and 36 h 95% O2. Message returned to near air-control levels by 60 h, as determined by Northern hybridization shown in Figure 1, with no significant change in 18S RNA. The total RNA recovered per lung was relatively constant except for 60 h 95% O2: air = 21.7 ± 4.4 µg/lung; 12 h = 20.3 ± 4.0; 36 h = 26.7 ± 4.2; 60 h = 36.6 ± 5.1 (mean ± SD). The increase in recovered RNA was not statistically significant compared with the amount recovered at 36 h, but approached significance when compared with air and 12 h 95% O2, P = 0.07.
|
|
Semiquantitative in situ hybridization and immunohistochemistry. Because local effects of hyperoxia on SP-D may differ by cell type and location, we performed semiquantitative measurements of SP-D mRNA and SP-D immunolabeling signal classified by numbers of labeled alveolar epithelium (AE) or bronchiolar epithelium (BE) cells. Positive cells were classified by intensity as shown in Figure 3. Based on the morphometric measurements, a total of 158 million type II AE cells and 15.5 million Clara cells were present in air-exposed rats. Values of 125 million AE cells and 17.3 Clara cells have previously been reported in rats of comparable size (31). Measurements of total numbers of AE and BE cells in hyperoxia-exposed animals did not differ significantly from control, so changes in SP-D mRNA abundance likely reflect changes in cell-specific expression rather than loss of SP-D expressing cells during hyperoxia exposure.
In situ RNA hybridizations (Figure 4) demonstrate SP-D mRNA in AE and BE as previously shown (33). The overall effect on AE cells paralleled the Northern blot results. By 12 h of hyperoxia, SP-D was increased in both cell types, with a nearly threefold increase in the number of labeled AE cells, as shown in Figure 5. Label intensity was also increased in AE cells. At 36 h of hyperoxia, labeled AE and BE cell numbers declined from the 12 h levels and were reduced to near control levels by 60 h of hyperoxia. The effects on label intensity in AE cells also paralleled the Northern blot results. By 60 h of hyperoxia, the SP-D mRNA signals in both AE and BE cells were reduced to levels near air control. There was no hybridization signal seen in the sense cRNA-hybridized assay controls or in RNase-pretreated assay controls (see inset, Figure 4).
|
|
|
|
| |
Discussion |
|---|
|
|
|---|
We studied the effects of 95% O2 on expression of SP-D and its mRNA at exposure durations of 12, 36, and 60 h compared with air exposure because we previously determined that there were decreases in SP-A expression following 12 h 95% O2 (34). Both SP-D and SP-A play roles in lung response to bacterial and viral pathogens. If hyperoxia results in significant sustained depression of SP-D expression, it may adversely affect pulmonary defense against microbial invasion, particularly in lung injury conditions necessitating supplemental oxygen treatment.
We found that SP-D was depressed after 12 h of 95% O2 in whole lung through its effect on AE cell expression, as shown by the parallel responses in Western blots and immunohistochemistry results. This was sustained throughout the exposure up to 60 h. Alveolar-capillary leak due to hyperoxia-induced lung injury might have led to loss of immunodetectable SP-D from epithelium into the airways, and to subsequent phagocytosis and clearance by alveolar macrophages, leading to decreased SP-D detected in whole lung. Further studies using pulse labeling of SP-D may elucidate the fate of newly synthesized and secreted SP-D in acute lung injury states. This may be particularly important because a decrease in SP-D detected in whole lung occurred when the SP-D mRNA in whole lung was increased. If newly synthesized SP-D were cleared from airways by alveolar macrophages and reached the circulation, then the amount of immunodetectable SP-D in the lung might underestimate the SP-D translated from newly transcribed SP-D mRNA. This possibility is suggested by observations that increased SP-D has been detected in the circulation in clinical lung injury states (35). There may also be a lag between elevations in SP-D mRNA abundance and increased SP-D translation, as has been shown with manganese superoxide dismutase following hyperoxia exposure (36). Clarifying the nature of the dose-response of SP-D expression to hyperoxia may require even shorter exposures, and at different FIO2.
Hyperoxia appears to affect specific SP-D mRNA accumulation at 12 and 36 h 95% O2, as SP-D mRNA was increased but total RNA and 18S RNA signal were unchanged. It is possible that there were global effects of 95% O2 exposure on mRNA as a proportion of total RNA, which might affect the results, but this was not directly tested because the focus of our experiments was on cell-specific effects.
The suppressive effects of hyperoxia on SP-D were primarily in AE as shown in Figures 5 and 7. In contrast, immunolabeled BE cells tended to increase at 12 and 36 h of hyperoxia, followed by a decline at 60 h, in parallel with the in situ RNA hybridization results, although this did not achieve statistical significance (P = 0.15). The coordinate increases in BE SP-D immunolabeling and in situ RNA abundance are consistent with increased mRNA transcription and consequent SP-D synthesis in BE cells. We speculate that decreased SP-D secretion or metabolism, or uptake in BE cells could also account for the apparent increase in immunolabeling, both in number and intensity, although uptake of SP-D by BE cells has not been demonstrated to our knowledge. This differential effect of injury on SP-D abundance in AE and BE cells has also been seen in radiation injury (37). Similar noncoordinate effects of hyperoxia have been noted in SP-A expression in AE and BE cells (17). The effects of hyperoxia on SP-D mRNA in situ hybridization signal in AE cells did not parallel the effects on immunolabeling in contrast with the pattern seen in BE cells, possibly because of increased secretion of SP-D from AE into airways and clearance from the lung compartment as discussed previously.
The apparent differential effects of hyperoxia on AE and BE immunolabeling may be attributable to oxidative effects on the carbohydrate-binding domain, the anti-SP-D epitope, which might alter antibody detection. Oxidative stress has had similar effects on the carbohydrate-binding domain in SP-A (38). In addition, secretory pathways for SP-D differ between the cell types, which may affect antigen exposure or preservation with oxidant stress. In BE cells, SP-D is prominently labeled in secretory granules (42), but in AE cells the endoplasmic reticulum is most prominently labeled (43).
Precise cellular quantitation using immunologic detection of SP-D or labeled SP-D mRNA hybrids can be problematic. Both methods exhibited sufficiently low background in these experiments to permit counting positively labeled cells using the criteria listed in MATERIALS AND METHODS. The intensity grading system is arbitrary, so firm conclusions about the overall amount of mRNA or protein per cell cannot be made. The overall effects of hyperoxia on SP-D expression in lung were corroborated by whole-lung studies. Image analysis of nonisotopically labeled in situ hybridization may permit more accurate quantitation in the future (44), but the methodology is not yet well established. The principal strength of the in situ detection in the present studies is to demonstrate and distinguish the relative contribution of the different cell types to the injury response. This may be of particular importance for understanding localized effects on lung immunity in injury states, as it may influence the clinical manifestation of pulmonary infection.
The pattern of SP-D responses in lung injury models is variable. We found an acute rise in SP-D mRNA after brief hyperoxia exposure, as was noted after acute lipopolysaccharide administration (23). In other studies, proinflammatory stimulus with cytokines and endotoxin did not increase SP-D immunolabeling in intact lung (45), nor did they increase SP-D mRNA expression in fetal lung explant (46). Keratinocyte growth factor may be a required cytokine for SP-D induction, particularly in isolated cell culture (47).
The role of SP-D in pulmonary host defense includes opsonization, ligand binding, and macrophage signaling (8, 48, 49). Although it shares substantial homology with SP-A, particularly in the lectin domain (50, 51), it demonstrates differential ontogeny in fetal development (46) and responses to hormonal regulation and injury response. The depressive effects of 95% O2 exposure on SP-D protein in alveolar cells, which developed after only 12 h of hyperoxia and which were sustained throughout the exposure duration, may alter the capacity of the lung to opsonize a number of pathogens or signal alveolar macrophage clearance of pathogens, particularly in lung injury states requiring high levels of oxygen therapy such as pneumonia or adult/acute respiratory distress syndrome. This may be particularly relevant in patients colonized with Pseudomonas aeruginosa (or other gram-negative bacteria [4]), or in patients with influenza (52).
In summary, these studies indicate that brief hyperoxia exposure decreases SP-D abundance in adult rat lung, accompanied by alterations in SP-D gene expression. The responses to brief hyperoxia are differentially regulated in BE and AE, and may lead to alterations in SP-D-mediated host defense following hyperoxia exposure, particularly in alveoli. Studies of the infectivity and clearance of microbial SP-D ligands in vivo following hyperoxia may help determine the significance of this effect.
| |
Footnotes |
|---|
Address correspondence to: R. L. Auten, DUMC Box 3179, Durham, NC 27710. E-mail: auten{at}acpub.duke.edu
(Received in original form February 25, 1998 and in revised form May 27, 1998).
Abbreviations: alveolar epithelium, AE; bronchiolar epithelium, BE; ethylenediamine tetraacetic acid, EDTA; phosphate-buffered saline-1% Tween-20, PBS-T; sodium dodecyl sulfate, SDS; surfactant protein D, SP-D; saline sodium citrate, SSC; Tris-buffered saline, TBS; ultraviolet, UV.Acknowledgments: The authors thank Jo Rae Wright and Samuel Hawgood for providing polyclonal antirat SP-D antibodies. They also thank Dr. James Fisher for the gift of rat SP-D cDNA, and Dr. Wright and Dr. Judith Voynow for the critical review of this manuscript. This study was supported in part by a grant from Wyeth Pediatrics.
| |
References |
|---|
|
|
|---|
1.
Crouch, E.,
A. Persson,
D. Chang, and
J. Heuser.
1994.
Molecular structure
of pulmonary surfactant protein D (SP-D).
J. Biol. Chem.
269:
17311-17319
2. Van Iwaarden, J. F., H. Shimizu, P. H. VanGolde, D. R. Voelker, and L. M. VanGolde. 1992. Rat surfactant protein D enhances the production of oxygen radicals by rat alveolar macrophages. Biochem. J. 286: 5-8 .
3. Miyamura, K., L. E. Leigh, J. Lu, J. Hopkin, B. A. Lopez, and K. B. Reid. 1994. Surfactant protein D binding to alveolar macrophages. Biochem. J. 300: 237-242 .
4. Lim, B. L., J. Y. Wang, U. Holmskov, H. J. Hoppe, and K. B. Reid. 1994. Expression of the carbohydrate recognition domain of lung surfactant protein D and demonstration of its binding to lipopolysaccharides of gram-negative bacteria. Biochem. Biophys. Res. Commun. 202: 1674-1680 [Medline].
5. Kuan, S. F., K. Rust, and E. Crouch. 1992. Interactions of surfactant protein D with bacterial lipopolysaccharides: surfactant protein D is an Escherichia coli-binding protein in bronchoalveolar lavage. J. Clin. Invest. 90: 97-106 .
6. Blau, H., V. Kravtsov, S. Rilkis, and M. Kalina. 1994. Surfactant protein A (SP-A) binds to bacterial lipopolysaccharide with inhibition of SP-A mediated CSF secretion and phagocytosis by alveolar macrophages. Am. J. Respir. Crit. Care Med. 149: A239 . (Abstr.) .
7. O'Riordan, D. M., J. E. Standing, K. Y. Kwon, D. Chang, E. C. Crouch, and A. H. Limper. 1995. Surfactant protein D interacts with Pneumocystis carinii and mediates organism adherence to alveolar macrophages. J. Clin. Invest. 95: 2699-2710 .
8. Malhotra, R., J. S. Haurum, S. Thiel, and R. B. Sim. 1994. Binding of human collectins (SP-A and MBP) to influenza virus. Biochem. J. 304: 455-461 .
9.
Brown-Augsburger, P.,
K. Hartshorn,
D. Chang,
K. Rust,
C. Fliszar,
H. G. Welgus, and
E. C. Crouch.
1996.
Site-directed mutagenesis of Cys-15 and
Cys-20 of pulmonary surfactant protein D: expression of a trimeric protein
with altered anti-viral properties.
J. Biol. Chem.
271:
13724-13730
10.
Hartshorn, K. L.,
K. B. Reid,
M. R. White,
J. C. Jensenius,
S. M. Morris,
A. I. Tauber, and
E. Crouch.
1996.
Neutrophil deactivation by influenza A
viruses: mechanisms of protection after viral opsonization with collectins
and hemagglutination-inhibiting antibodies.
Blood
87:
3450-3461
11.
Hartshorn, K.,
D. Chang,
K. Rust,
M. White,
J. Heuser, and
E. Crouch.
1996.
Interactions of recombinant human pulmonary surfactant protein D
and SP-D multimers with influenza A.
Am. J. Physiol.
271:
L753-L762
12. Hartshorn, K. L., E. C. Crouch, M. R. White, P. Eggleton, A. I. Tauber, D. Chang, and K. Sastry. 1994. Evidence for a protective role of pulmonary surfactant protein D (SP-D) against influenza A viruses. J. Clin. Invest. 94: 311-319 .
13. Benne, C. A., B. Benaissa-Trouw, J. A. van Strijp, C. A. Kraaijeveld, and J. F. van Iwaarden. 1997. Surfactant protein A, but not surfactant protein D, is an opsonin for influenza A virus phagocytosis by rat alveolar macrophages. Eur. J. Immunol. 27: 886-890 [Medline].
14. Dedhia, H., J. Ma, N. Dalal, D. Banks, E. Flink, M. Billie, V. Castranova, and M. Barger. 1993. Exposure of rats to hyperoxia: alteration of lavagate parameters and macrophage function. J. Toxicol. Environ. Health 40: 1-13 [Medline].
15. Minoo, P., L. Segura, J. J. Coalson, R. J. King, and R. A. DeLemos. 1991. Alterations in surfactant protein gene expression associated with premature birth and exposure to hyperoxia. Am. J. Physiol. 5: L386-L392 .
16. Minoo, P., R. J. King, and J. J. Coalson. 1992. Surfactant proteins and lipids are regulated independently during hyperoxia. Am. J. Physiol. 7: L291-L298 .
17. Horowitz, S., R. H. Watkins, R. J. Auten, C. E. Mercier, and E. R. Cheng. 1991. Differential accumulation of surfactant protein A, B, and C mRNAs in two epithelial cell types of hyperoxic lung. Am. J. Respir. Cell Mol. Biol. 5: 511-515 .
18. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidiniumthiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156-159 [Medline].
19. Sambrook, J., E. Fritsch, and T. Maniatis. 1989. Molecular Cloning: A Laboratory Manual, 2nd ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
20.
Shimizu, H.,
J. Fisher,
P. Papst,
B. Benson,
K. Lau,
R. Mason, and
D. Voelker.
1992.
Primary structure of rat pulmonary surfactant protein D:
cDNA and deduced amino acid sequence.
J. Biol. Chem.
267:
1853-1857
21.
Torczynski, R. M.,
A. P. Bollon, and
M. Fuke.
1983.
The complete nucleotide sequence of the rat 18S ribosomal RNA gene and comparison with
respective yeast and frog genes.
Nucleic Acids Res.
11:
4879-4890
22. Wong, C. J., J. Akiyama, L. Allen, and S. Hawgood. 1996. Localization and developmental expression of surfactant proteins D and A in the respiratory tract of the mouse. Pediatr. Res. 39: 930-937 [Medline].
23. McIntosh, J. C., A. H. Swyers, J. H. Fisher, and J. R. Wright. 1996. Surfactant proteins A and D increase in response to intratracheal lipopolysaccharide. Am. J. Respir. Cell Mol. Biol. 15: 509-519 [Abstract].
24. Ausubel, F. M., R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl, editors. 1989. Short Protocols in Molecular Biology. Wiley-Interscience, New York.
25. Auten, R. L., R. H. Watkins, D. L. Shapiro, and S. Horowitz. 1990. Surfactant apoprotein A (SP-A) is synthesized in airway cells. Am. J. Respir. Cell Mol. Biol. 3: 491-496 .
26. Gruenewald-Janho, S., J. Keesey, M. Leous, R. vanMiltenburg, and C. Schroeder, editors. 1996. Nonradioactive In Situ Hybridization, 2nd ed. Boehringer Mannheim Corporation, Mannheim, Germany.
27. Cox, K. J., D. V. DeLeon, L. M. Angerer, and R. C. Angerer. 1983. Detection of mRNAs in sea urchin embryos by in situ hybridization using asymmetric RNA probes. Dev. Biol. 100: 197-206 [Medline].
28. Weibel, E. R. 1980. Stereological Methods: Practical Methods for Biological Morphometry. Academic Press, New York.
29. Stone, K. C., R. R. Mercer, P. Gehr, B. Stockstill, and J. D. Crapo. 1992. Allometric relationships of cell numbers and size in mammalian lung. Am. J. Respir. Cell Mol. Biol. 6: 235-243 .
30.
Mercer, R. R.,
J. M. Laco, and
J. D. Crapo.
1987.
Three-dimensional reconstruction of alveoli in the rat lung for pressure-volume relationships.
J.
Appl. Physiol.
62:
1480-1487
31. Mercer, R. R., M. L. Russell, V. L. Roggli, and J. D. Crapo. 1994. Cell number and distribution in human and rat airways. Am. J. Respir. Cell Mol. Biol. 10: 613-624 [Abstract].
32. Gunderson, H. J. G.. 1977. Notes on the estimation of the numerical density of arbitrary profiles: the edge effect. J. Microsc. Oxf. 111: 219-223 .
33. Mariencheck, W., and E. Crouch. 1994. Modulation of surfactant protein D expression by glucocorticoids in fetal rat lung. Am. J. Respir. Cell Mol. Biol. 10: 419-429 [Abstract].
34. Allred, T. F., R. F. Thomas, and R. L. Auten. 1994. Surfactant apoprotein A, B, and C mRNA are suppressed after brief exposures to 95% oxygen in rats. Am. J. Respir. Crit. Care Med. 149: A99 . (Abstr.) .
35. Honda, Y., Y. Kuroki, E. Matsuura, H. Nagae, H. Takahashi, T. Akino, and S. Abe. 1995. Pulmonary surfactant protein D in sera and bronchoalveolar lavage fluids. Am. J. Respir. Crit. Care Med. 152: 1860-1866 [Abstract].
36.
Ho, Y. S.,
M. S. Dey, and
J. D. Crapo.
1996.
Antioxidant enzyme expression
in rat lungs during hyperoxia.
Am. J. Physiol.
270:
L810-L818
37. Kasper, M., S. Albrecht, H. Grossmann, M. Grosser, D. Schuh, and M. Muller. 1995. Monoclonal antibodies to surfactant protein D: evaluation of immunoreactivity in normal rat lung and in a radiation-induced fibrosis model. Exp. Lung Res. 21: 577-588 [Medline].
38.
Su, W. Y., and
T. Gordon.
1996.
Alterations in surfactant protein A after
acute exposure to ozone.
J. Appl. Physiol.
80:
1560-1567
39. Zhu, S., I. Y. Haddad, and S. Matalon. 1996. Nitration of surfactant protein A (SP-A) tyrosine residues results in decreased mannose binding ability. Arch. Biochem. Biophys. 333: 282-290 [Medline].
40.
Haddad, I. Y.,
S. Zhu,
H. Ischiropoulos, and
S. Matalon.
1996.
Nitration of
surfactant protein A results in decreased ability to aggregate lipids.
Am. J. Physiol.
270:
L281-L288
41.
Haddad, I. Y.,
B. Nieves-Cruz, and
S. Matalon.
1997.
Inhibition of surfactant function by copper-zinc superoxide dismutase (CuZn-SOD).
J. Appl.
Physiol.
83:
1545-1550
42.
Crouch, E.,
D. Parghi,
S. F. Kuan, and
A. Persson.
1992.
Surfactant protein
D: subcellular localization in nonciliated bronchiolar epithelial cells.
Am.
J. Physiol.
263:
L60-L66
43. Voorhout, W. F., T. Veenendaal, Y. Kuroki, Y. Ogasawara, L. M. van Golde, and H. J. Geuze. 1992. Immunocytochemical localization of surfactant protein D (SP-D) in type II cells, Clara cells, and alveolar macrophages of rat lung. J. Histochem. Cytochem. 40: 1589-1597 [Abstract].
44. Larsson, L. I., B. Traasdahl, and D. M. Hougaard. 1991. Quantitative non-radioactive in situ hybridization: model studies and studies on pituitary proopiomelanocortin cells after adrenalectomy. Histochemistry 95: 209-215 [Medline].
45. Lewis-Molock, Y., K. Suzuki, N. Taniguchi, D. H. Nguyen, R. J. Mason, and C. W. White. 1994. Lung manganese superoxide dismutase increases during cytokine-mediated protection against pulmonary oxygen toxicity in rats. Am. J. Respir. Cell Mol. Biol. 10: 133-141 [Abstract].
46. Dulkerian, S. J., L. W. Gonzales, Y. Ning, and P. L. Ballard. 1996. Regulation of surfactant protein D in human fetal lung. Am. J. Respir. Cell Mol. Biol. 15: 781-786 [Abstract].
47.
Xu, X.,
K. McCormick-Shanon,
D. R. Voelker, and
R. J. Mason.
1998.
KGF
increases SP-A and SP-D mRNA levels and secretion in cultured rat alveolar type II cells.
Am. J. Respir. Cell Mol. Biol.
18:
168-178
48. Kuan, S. F., A. Persson, D. Parghi, and E. Crouch. 1994. Lectin-mediated interactions of surfactant protein D with alveolar macrophages. Am. J. Respir. Cell Mol. Biol. 10: 430-436 [Abstract].
49. McNeely, T. B., and J. D. Coonrod. 1993. Comparison of the opsonic activity of human surfactant protein A for Staphylococcus aureus and Streptococcus pneumoniae with rabbit and human macrophages. J. Infect. Dis. 167: 91-97 [Medline].
50. Kolble, K., J. Lu, S. E. Mole, S. Kaluz, and K. B. Reid. 1993. Assignment of the human pulmonary surfactant protein D gene (SFTP4) to 10q22-q23 close to the surfactant protein A gene cluster. Genomics 17: 294-298 [Medline].
51. Motwani, M., R. A. White, N. Guo, L. L. Dowler, A. I. Tauber, and K. N. Sastry. 1995. Mouse surfactant protein-D: cDNA cloning, characterization, and gene localization to chromosome 14. J. Immunol. 155: 5671-5677 [Abstract].
52. Limper, A. H., D. M. O'Riordan, Z. Vuk-Pavlovic, and E. C. Crouch. 1994. Accumulation of surfactant protein D in the lung during Pneumocystis carinii pneumonia. J. Eukaryot. Microbiol. 41: 98S [Medline].
This article has been cited by other articles:
![]() |
D. Jain, E. Atochina-Vasserman, H. Kadire, Y. Tomer, A. Inch, P. Scott, R. C. Savani, A. J. Gow, and M. F. Beers SP-D-deficient mice are resistant to hyperoxia Am J Physiol Lung Cell Mol Physiol, April 1, 2007; 292(4): L861 - L871. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Casey, J. Kaplan, E. N. Atochina-Vasserman, A. J. Gow, H. Kadire, Y. Tomer, J. H. Fisher, S. Hawgood, R. C. Savani, and M. F. Beers Alveolar Surfactant Protein D Content Modulates Bleomycin-induced Lung Injury Am. J. Respir. Crit. Care Med., October 1, 2005; 172(7): 869 - 877. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Dave, T. Childs, and J. A. Whitsett Nuclear Factor of Activated T Cells Regulates Transcription of the Surfactant Protein D Gene (Sftpd) via Direct Interaction with Thyroid Transcription Factor-1 in Lung Epithelial Cells J. Biol. Chem., August 13, 2004; 279(33): 34578 - 34588. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. N. Ahmed, H. B. Suliman, R. J. Folz, E. Nozik-Grayck, M. L. Golson, S. N. Mason, and R. L. Auten Extracellular Superoxide Dismutase Protects Lung Development in Hyperoxia-exposed Newborn Mice Am. J. Respir. Crit. Care Med., February 1, 2003; 167(3): 400 - 405. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. He and E. Crouch Surfactant Protein D Gene Regulation. INTERACTIONS AMONG THE CONSERVED CCAAT/ENHANCER-BINDING PROTEIN ELEMENTS J. Biol. Chem., May 24, 2002; 277(22): 19530 - 19537. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. T. Stahlman, M. E. Gray, W. M. Hull, and J. A. Whitsett Immunolocalization of Surfactant Protein-D (SP-D) in Human Fetal, Newborn, and Adult Tissues J. Histochem. Cytochem., May 1, 2002; 50(5): 651 - 660. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Auten, M. H. Whorton, and S. Nicholas Mason Blocking Neutrophil Influx Reduces DNA Damage in Hyperoxia-Exposed Newborn Rat Lung Am. J. Respir. Cell Mol. Biol., April 1, 2002; 26(4): 391 - 397. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Auten Jr., S. N. Mason, D. T. Tanaka, K. Welty-Wolf, and M. H. Whorton Anti-neutrophil chemokine preserves alveolar development in hyperoxia-exposed newborn rats Am J Physiol Lung Cell Mol Physiol, August 1, 2001; 281(2): L336 - L344. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. DENG, S. NICHOLAS MASON, and R. L. AUTEN Jr. Lung Inflammation in Hyperoxia Can Be Prevented By Antichemokine Treatment in Newborn Rats Am. J. Respir. Crit. Care Med., December 1, 2000; 162(6): 2316 - 2323. [Abstract] [Full Text] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Proc. Am. Thorac. Soc. | Am. J. Respir. Crit. Care Med. |